TickerGuard
Buy Day today: Poor (57) Mixed market breadth · today: Nonfarm Payrolls (September)
IMCR

Immunocore Holdings Ltd

Healthcare · Biotechnology

30.50$ +0.8% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

Immunocore Holdings Ltd (IMCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,119 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IMCR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
464 597 994 1,023 1,085 1,010 1,028 1,082 1,103 1,067 1,072 1,119
416 529 926 957 1,006 930 949 1,002 1,023 997 1,004 1,051
364 443 833 505 538 456 477 488 498 468 453 485
364 443 833 860 901 820 837 883 892 864 845 880
50 61 58 60 64 83 63 70 76 74 81 95
1.9 4.5 4.2 3.5 4.5 5.4 6.8 5.5 5.7 6.7 8.3 7.8
34 – – – – – – – – – – –
1.6 – – – – – – – – – – –
173 228 634 664 707 649 650 694 706 686 678 700
98 139 155 185 266 212 149 170 170 247 240 235
2.3 1.4 1.2 1.4 49 1.5 1.7 1.8 1.9 2.0 2.0 1.9
11 18 16 20 20 25 29 24 23 24 30 26
38 48 438 438 390 391 392 392 393 393 394 394
291 369 360 359 378 361 378 388 397 381 394 420
-290 -745 -769 -781 -772 -796 -791 -801 -801 -831 -818 -819
54 49 50 50 53 50 52 50 50 50 53 51

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?